Given that elevated ACE2 expression level has been observed in AD patients [34], it is possible that the excess in ACE2 in AD provides more cellular receptors when exposed to SARS-CoV-2, and therefore increases the vulnerability to COVID-19. This evidence concerns the gene ACE2 and Alzheimer disease.